Vertex Pharmaceuticals
VRTX
#155
Rank
โ‚น12.280 T
Marketcap
โ‚น48,437
Share price
-2.94%
Change (1 day)
30.01%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): โ‚น1,460

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,458. In 2025 the company made an earnings per share (EPS) of โ‚น1,439 an increase over its 2024 EPS that were of -โ‚น191.64.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,4601.45%
2025โ‚น1,439-850.97%
2024-โ‚น191.64-114.67%
2023โ‚น1,3068.17%
2022โ‚น1,20842.64%
2021โ‚น846.57-12.67%
2020โ‚น969.37128.01%
2019โ‚น425.15-44.54%
2018โ‚น766.57670.09%
2017โ‚น99.54-327.66%
2016-โ‚น43.72-79.65%
2015-โ‚น214.90-26.43%
2014-โ‚น292.1153.92%
2013-โ‚น189.78316.33%
2012-โ‚น45.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น621.42-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น544.38-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น288.39-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.38-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น420.50-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚น224.20-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA